AAAAAA
Results:
1-25
|
Results: 25
Authors:
LODDENKEMPER R
KLOPPENBORG A
SCHOENFELD N
GROSSER H
COSTABEL U
Citation: R. Loddenkemper et al., CLINICAL FINDINGS IN 715 PATIENTS WITH NEWLY DETECTED PULMONARY SARCOIDOSIS - RESULTS OF A COOPERATIVE STUDY IN FORMER WEST-GERMANY AND SWITZERLAND, Sarcoidosis vasculitis and diffuse lung diseases, 15(2), 1998, pp. 178-182
Authors:
LODDENKEMPER R
Citation: R. Loddenkemper, THORACOSCOPY - STATE-OF-THE-ART, The European respiratory journal, 11(1), 1998, pp. 213-221
Authors:
LODDENKEMPER R
Citation: R. Loddenkemper, ARE PROGNOSTIC FACTORS HELPFUL IN DETERMINING THE INDICATION FOR PLEURODESIS IN MALIGNANT PLEURAL EFFUSIONS, Respiration, 65(2), 1998, pp. 106-107
Authors:
LODDENKEMPER R
Citation: R. Loddenkemper, EXERCISE TESTING IN PATIENTS WITH INTERSTITIAL LUNG-DISEASE, Chest, 113(4), 1998, pp. 1149-1149
Authors:
CASCORBI I
HENNING S
BROCKMOLLER J
JAHNKE V
LODDENKEMPER R
ROOTS I
Citation: I. Cascorbi et al., DIFFERENTIAL IMPACT OF POLYMORPHIC NAT2 AND CYP1A1 TO LUNG AND LARYNGEAL-CANCER, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 620-620
Authors:
ERBES R
SCHABERG T
LODDENKEMPER R
Citation: R. Erbes et al., LUNG-FUNCTION TESTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS - ARE THEY HELPFUL FOR PREDICTING OUTCOME, Chest, 111(1), 1997, pp. 51-57
Authors:
SCHOENFELD N
SCHMOLKE B
FRITZSCHE A
LODDENKEMPER R
Citation: N. Schoenfeld et al., LAMININ FRAGMENT P1 IN THE SERA OF PATIENTS WITH PULMONARY SARCOIDOSIS, Sarcoidosis vasculitis and diffuse lung diseases, 13(2), 1996, pp. 135-138
Authors:
SCHOENFELD N
RAHN W
LODDENKEMPER R
Citation: N. Schoenfeld et al., 22-YEAR SURVIVAL AFTER INCOMPLETE RESECTION OF ADVANCED ADENOID CYSTIC BRONCHOGENIC-CARCINOMA, The European respiratory journal, 9(7), 1996, pp. 1560-1561
Authors:
ANTHONY P
AUSSEIL J
BECHLER B
BENGURIA A
BLACKHALL N
BRIARTY LG
COGOLI A
DAVEY MR
GARESSE R
HAGER R
LODDENKEMPER R
MARCHANT R
MARCO R
MARTHY HJ
PERRY M
POWER JB
SCHILLER P
UGALDE C
VOLKMANN D
WARDROP J
Citation: P. Anthony et al., PRESERVATION OF VIABLE BIOLOGICAL SAMPLES FOR EXPERIMENTS IN-SPACE LABORATORIES, Journal of biotechnology, 47(2-3), 1996, pp. 377-393
Authors:
CASCORBI I
BROCKMOLLER J
MROZIKIEWICZ PM
BAUER S
LODDENKEMPER R
ROOTS I
Citation: I. Cascorbi et al., HOMOZYGOUS RAPID ARYLAMINE N-ACETYLTRANSFERASE (NAT2) GENOTYPE AS A SUSCEPTIBILITY FACTOR FOR LUNG-CANCER, Cancer research, 56(17), 1996, pp. 3961-3966
Authors:
SCHABERG T
SCHONFELD N
LODDENKEMPER R
LODE H
Citation: T. Schaberg et al., TREATMENT OF SARCOIDOSIS, Deutsche Medizinische Wochenschrift, 120(20), 1995, pp. 725-727
Authors:
SCHONFELD N
SCHABERG T
LODE H
LODDENKEMPER R
Citation: N. Schonfeld et al., DIAGNOSIS OF SARCOIDOSIS, Deutsche Medizinische Wochenschrift, 120(19), 1995, pp. 687-689
Authors:
FRANK W
LODDENKEMPER R
Citation: W. Frank et R. Loddenkemper, FIBER-ASSOCIATED PLEURAL DISEASE, Seminars in respiratory and critical care medicine, 16(4), 1995, pp. 315-323
Authors:
BITTNER RC
SCHNOY N
SCHONFELD N
GRASSOT A
LODDENKEMPER R
LODE H
KAISER D
KRUMHAAR D
FELIX R
Citation: Rc. Bittner et al., HIGH-RESOLUTION MAGNETIC-RESONANCE-IMAGIN G (HR-MRI) OF THE PLEURA CHEST-WALL - NORMAL FINDINGS AND PATHOLOGICAL-CHANGES, RoFo. Fortschritte auf dem Gebiete der Rontgenstrahlen und der neuenbildgebenden Verfahren, 162(4), 1995, pp. 296-303
Authors:
LODDENKEMPER R
Citation: R. Loddenkemper, PULMONOLOGY NOT GETTING ENOUGH RECOGNITIO N (VOL 89, PG 511, 1994), Medizinische Klinik, 90(4), 1995, pp. 3-3
Authors:
SCHOENFELD N
SCHMITT M
REMY N
ELLENSOHN P
LODDENKEMPER R
WAHN U
Citation: N. Schoenfeld et al., ACTIVATION OF BRONCHOALVEOLAR LAVAGE T-LYMPHOCYTES AND CLINICAL, FUNCTIONAL AND RADIOLOGICAL FEATURES IN SARCOIDOSIS, Sarcoidosis, 12(2), 1995, pp. 135-139
Authors:
MATHUR NP
LODDENKEMPER R
Citation: Np. Mathur et R. Loddenkemper, MEDICAL THORACOSCOPY - ROLE IN PLEURAL AND LUNG-DISEASES, Clinics in chest medicine, 16(3), 1995, pp. 487
Authors:
DIJKMAN JH
DELRIO JMG
LODDENKEMPER R
PROWSE K
SIAFAKAS N
Citation: Jh. Dijkman et al., REPORT OF THE WORKING PARTY OF THE UEMS MONOSPECIALITY SECTION ON PNEUMOLOGY AN TRAINING REQUIREMENTS AND FACILITIES IN EUROPE, The European respiratory journal, 7(5), 1994, pp. 1019-1022
Authors:
LODDENKEMPER R
Citation: R. Loddenkemper, PULMONOLOGY NOT GETTING ENOUGH RECOGNITIO N, Medizinische Klinik, 89(9), 1994, pp. 511-511
Authors:
SCHOENFELD N
SCHMOLKE B
SCHMITT M
REMY N
ELLENSOHN P
WAHN U
LODDENKEMPER R
Citation: N. Schoenfeld et al., SPECIFICATION AND QUANTITATION OF CIRCULATING IMMUNE-COMPLEXES IN THESERUM OF PATIENTS WITH ACTIVE PULMONARY SARCOIDOSIS, Thorax, 49(7), 1994, pp. 688-691
Authors:
BOUTIN C
LODDENKEMPER R
ASTOUL P
Citation: C. Boutin et al., DIAGNOSTIC AND THERAPEUTIC THORACOSCOPY - TECHNIQUES AND INDICATIONS IN PULMONARY MEDICINE, Tubercle and lung disease, 74(4), 1993, pp. 225-239
Authors:
LODDENKEMPER R
BOUTIN C
Citation: R. Loddenkemper et C. Boutin, THORACOSCOPY - PRESENT DIAGNOSTIC AND THERAPEUTIC INDICATIONS, The European respiratory journal, 6(10), 1993, pp. 1544-1555
CLINICAL AND RADIOLOGIC FEATURES, LUNG-FUNCTION AND THERAPEUTIC RESULTS IN PULMONARY HISTIOCYTOSIS-X
Authors:
SCHONFELD N
FRANK W
WENIG S
UHRMEISTER P
ALLICA E
PREUSSLER H
GRASSOT A
LODDENKEMPER R
Citation: N. Schonfeld et al., CLINICAL AND RADIOLOGIC FEATURES, LUNG-FUNCTION AND THERAPEUTIC RESULTS IN PULMONARY HISTIOCYTOSIS-X, Respiration, 60(1), 1993, pp. 38-44
Authors:
ERBES R
SCHABERG T
LODDENKEMPER R
Citation: R. Erbes et al., PROGNOSIS OF IDIOPATHIC PULMONARY FIBROSIS IN DEPENDENCE ON CLINICAL AND LUNG-FUNCTION PARAMETERS, The American review of respiratory disease, 147(4), 1993, pp. 589-589
Authors:
SCHOENFELD N
MATTHIESSEN W
HELLWEG U
LODDENKEMPER R
Citation: N. Schoenfeld et al., 2ND-LINE CHEMOTHERAPY IN ADVANCED NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT, The American review of respiratory disease, 147(4), 1993, pp. 750-750
Risultati:
1-25
|